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Suppression of CD8+ T cell activation is a critical mechanism used by Mycobacterium
tuberculosis (MTB) to escape protective host immune responses. PPE38 belongs to the
unique PPE family of MTB and in our previous study, PPE38 protein was speculated to
participate in manipulating macrophage MHC class I pathway. To test this hypothesis,
the function of mycobacterial PPE38 protein was assessed here using macrophage and
mouse infection models. Decreased amount of MHC class I was observed on the surface
of macrophages infected with PPE38-expressing mycobacteria. The transcript of genes
encoding MHC class I was also inhibited by PPE38. After infection of C57BL/6 mice with
Mycobacterium smegmatis expressing PPE38 (Msmeg-PPE38), decreased number of
CD8+ T cells was found in spleen, liver, and lungs through immunohistochemical analysis,
comparing to the control strain harboring empty vector (Msmeg-V). Consistently, flow
cytometry assay showed that fewer effector/memory CD8+ T cells (CD44highCD62Llow)
were activated in spleen from Msmeg-PPE38 infected mice. Moreover, Msmeg-PPE38
confers a growth advantage over Msmeg-V in C57BL/6 mice, indicating an effect of
PPE38 to favor mycobacterial persistence in vivo. Overall, this study shows a unique
biological function of PPE38 protein to facilitate mycobacteria to escape host immunity,
and provides hints for TB vaccine development.
Keywords: Mycobacterium, PPE38, MHC class I, CD8+ T cells, macrophages
INTRODUCTION
Tuberculosis (TB) is an ancient disease caused by Mycobacterium tuberculosis (MTB), a pathogen
that infects one-third of the world’s population. Most infected people develop a long lasting
protective immune response, while about 3–10% will develop active infections during their lifetime
(Zumla et al., 2011).
Previous studies have established that CD4+ T cells and CD8+ T cells play key roles in
controlling MTB infection (Lindestam Arlehamn et al., 2014; Jasenosky et al., 2015). CD4+
T cells, which recognize antigenic peptides derived from the phagosomal compartment in the
context of major histocompatibility complex (MHC) class II molecules, are crucial to control of
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initial infection by MTB as well as preventing recurrence
(Kaufmann et al., 2005). The higher mortality rates of HIV-MTB
patients emphasize the essential immunity function of the class II
MHC-restricted CD4+ T cells (Kaufmann et al., 2010; Bradshaw
et al., 2016).
In addition to CD4+ T cells, CD8+ T cells are also essential
in the host defense against MTB infection. Classically, CD8+ T
cells recognize antigens derived from proteins in the cytosolic
compartment through MHC class I. First, cytosolic antigens are
digested proteolytically by the proteasome and other proteases.
After binding with antigen peptide transporter (TAP) complexes,
the peptides are then transported into the endoplasmic reticulum
(ER). In the ER, the peptides form a complex with MHC class
I and are exported to the plasma membrane, where they are
recognized by CD8+ T cells (Heemels and Ploegh, 1995; Rock
et al., 2002; Abele and Tampe, 2009). In animal infection models,
mice lacking β2-microglobulin (β2m), which is required for
assembly of MHC class I heavy chain, died quickly after MTB
infection (Flynn et al., 1992). Moreover, antigen processing
(TAP)-1(−/−) or CD8 (−/−) knockout mice with disruptions
of the MHC class I antigen processing pathway or/and functional
CD8+ T cells are more susceptible to MTB infection (Flynn et al.,
1992; Behar et al., 1999; Sousa et al., 2000; Turner et al., 2001;
Urdahl et al., 2003). Moreover, both murine and human CD8+ T
cells could be activated by mycobacterial antigens (Ags) (Stenger
et al., 1997; Lalvani et al., 1998; Kamath et al., 2004, 2006; Irwin
et al., 2005;Woodworth et al., 2011). In TB patients, CD8+ T cells
were found in granulomas, indicating the recruitment of CD8+
T cells post-MTB infection (Munk and Emoto, 1995; Tully et al.,
2005).
Upon phagocytosis by macrophages, MTB survives and
proliferates in phagosomes. Although MTB Ag presentation by
MHC class I is not the canonical mode, there is increasing
evidence that endocytosed MTB Ags can be presented through
MHC class I, a process known as cross-presentation (Rock
and Shen, 2005; Jensen, 2007). Additionally, the MHC class
I-dependent process can also be activated once MTB escapes
or MTB proteins are exported from the phagosome into the
cytosol (van derWel et al., 2007; Behar et al., 2011). Furthermore,
apoptotic vesicles generated from infected macrophage cells can
be taken up by dendritic cells, where the peptides are shuttled
into the MHC class I pathway (Schaible et al., 2003; Winau et al.,
2006).
PPE38 protein belongs to the highly polymorphic proline-
proline-glutamic acid (PPE) family, which consists of 69 PPE
proteins encoded by the M. tuberculosis H37Rv (Cole et al.,
1998). PPE proteins are considered as pivotal candidates for
MTB vaccine development (Pajon et al., 2006; Bertholet et al.,
2008; Lewinsohn et al., 2013), and at least 10 PPE proteins are
able to elicit T cell responses (Sampson, 2011). Recently, a study
described that PPE65 inhibits both CD4+ and CD8+ T cell
activity by suppressing Th1 Cytokines (Khubaib et al., 2016).
However, it remains unclear whether MTBmodulates MHC class
I expression, which, in turn, influences CD8+ T cells activation.
The current study was undertaken to characterize the function
of a MTB virulence factor, PPE38, which may inhibit the
MHC class I process during mycobacterial infection. After
comparing the proteomic profiles of macrophages infected by
an M. marinum ppe38 mutant (Tn-MmPPE38) or the wild-
type (WT Mm), the expressions of TAP1, TAP2, and TAP
binding protein isoform 1 (TAPBP) which are involved in
MHC class I pathway, were significantly downregulated (Wang
et al., 2013). Besides, macrophages infected with MTB or Bacille
Calmette-Guerin (BCG) will present Ags through the TAP-
dependent MHC class I presentation pathway (Teitelbaum et al.,
1999), thus we speculated that the PPE38 protein may be
involved in antigen presentation, which ultimately influences
CD8+ T cells responses to escape host elimination. To test this
hypothesis, we first investigated the expression of MHC class I in
infected macrophages. Then, a mouse-Mycobacterium smegmatis
infection model was used to measure the activation of CD8+
T cells in the spleen. In addition, we assessed the amounts of
CD8+ T cells in infected organs and the in vivo survival of the
bacteria. Overall, this study contributed to our understanding of
TB pathogenesis, in particular how the bacteria escape the host
CD8+ T cell-dependent immunity.
MATERIALS AND METHODS
Mice and Cell Lines
C57BL/6 mice and BALB/c mice were purchased from the
Animal Center of Slaccas (Shanghai, China) and housed under
specific pathogen-free conditions in the Animal Center of
Fudan University. The experimental procedures followed the
Guidelines for the Care and Use of Laboratory Animals from the
National Institutes of Health and were approved by the Animal
Care and Use Ethical Committee of Fudan University. All the
procedures were carried out in accordance with the guidelines.
The RAW264.7 cell line was purchased from the Cell Bank
of the Chinese Academy of Sciences (Shanghai, China). Cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco, Grand Island, NY, USA) supplemented with 10% fetal
bovine serum (FBS), penicillin (100 U/ml) and streptomycin
(100 mg/ml) and maintained at 37◦C in a humidified incubator
(5% CO2).
Bacterial Strains
M. marinum M strain (ATCC BAA-535) was used in our
research. Strain Tn-MmPPE38 was generated by transposon
mutagenesis of Mycobacterium marinum (M. marinum). Both
Tn-MmPPE38 and its complemented strain (Comp-MmPPE38)
were constructed as described previously (Dong et al., 2012).
For generation of recombinant M. smegmatis expressing
PPE38, the ppe38 gene was amplified using PCR based on
the genomic DNA sequence of M. tuberculosis H37Rv with
specific primers (forward primer, F-5′-CGGGATCCTGGAGG
GGTTGCGATGATTTTTGGATTTTTC-3′ and reverse primer
R-5′-GGACTAGTACCGCTTCGGTGCACTTCATTTC-3′). The
PCR product were digested with BamHI and SpeI, and cloned
into pSMT3 to generate pRvppe38. The recombinant plasmid was
introduced intoM. smegmatis (Msmeg-PPE38 andMsmeg-V) via
electroporation. Msmeg-PPE68 was constructed in our previous
study (unpublished data).
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Bacterial Sample Preparation
M. marinum strains (WT Mm, Tn-MmPPE38, and Comp-
MmPPE38) and Msmeg-V and Msmeg-PPE38 cultures were
grown in Middlebrook 7H9 medium supplemented with 10%
OADC and 0.05% Tween 80 till OD600∼0.6. Bacterial cell pellets
were harvested and washed with phosphate buffer saline (PBS).
The single-cell suspension of bacteria was prepared by subjecting
cells to vortex 5 min with 1 mm glass beads, and passage through
a 5-µm syringe filter.
Cell Culture
The murine macrophage cell line RAW264.7 (ATCC TIB71)
was maintained at 37◦C with 5% CO2 in Dulbecco’s Modified
Eagle’s Medium (DMEM), supplemented with 10% fetal bovine
serum (FBS) and 10 mM HEPES. Peritoneal macrophages (PMs)
was isolated as described before (Lu et al., 2013). In brief, each
mouse was injected with 1 ml of aged 3% thioglycollate medium
via peritoneal injection. After 4–5 days, peritoneal cells were
harvested and cultured in RPMI 1640 medium with 10% FBS at
37◦C in 5% CO2.
Infection of Raw264.7 Macrophages by
Mycobacterium Strains
Prior to infection, RAW264.7 cells were seeded into 24-well plate
at a density of 2 × 105 cells per well and maintained at 37◦C
with 5% CO2. After overnight growth, the RAW264.7 cells were
infected with prepared Mycobacterium strains. Spent media was
replaced with 1ml of fresh DMEM media containing 10% FBS
and sufficient mycobacteria to achieve a multiplicity of infection
(MOI) of 10 (i.e., 10 bacteria for one macrophage). The infection
was allowed to proceed for 4 h for M. marinum at 32◦C, or 2
h for M. smegmatis strains at 37◦C in 5% CO2. The CFUs of
mycobacteria strains used was enumerated by plating appropriate
dilutions on Middlebrook 7H10 supplemented with 10% OADC
(C7H10) agar plates.
Flow Cytometric Analysis
Peritoneal macrophages (PMs) from C57BL/6 mice was isolated
following published protocols (Bermudez et al., 1997; Overbergh
et al., 2000). In brief, infected C57BL/6 mice were euthanized
at 6 h post infection (hpi), 1 day post infection (dpi) or 3 dpi.
PMs of each mouse were obtained by washing the peritoneal
cavity with 5 ml cold PBS. Macrophages was collected in sterile
15 ml tubes and placed immediately on ice. RAW264.7 or PMs
from infected C57BL/6 mice were harvested and washed with
pre-chilled PBS, followed by centrifugation at 1,000 × g for 10
min at 4◦C. The cells were treated with Fc Block (1:100) (BD
Pharmingen, CA, USA) in PBS supplemented with 1% BSA and
then incubated with Anti-Mouse CD11b FITC, F4/80, and Anti-
Mouse MHC Class I (H-2Kb) PE (eBioscience, USA) on ice for
15 min in the dark room. For splenic CD8+ T cell analysis,
at 6 dpi, spleens were collected and manually dissociated into
single cell suspension. The staining procedure was performed as
in the above, with CD44, CD62L. The cells were washed once
using PBS+10% FBS and resuspended in 200 µl FACS staining
buffer (eBioscience, USA), and analyzed using flow cytometers
FACSCalibur (Becton Dickinson, USA). The data were analyzed
using the Cell-Quest data analysis software (100,000 events per
sample) and FlowJo.
Real-Time Quantitative PCR
RAW264.7 RNA was purified using Trizol method. 1 µg
RNA was converted to cDNA using PrimeScriptTM II 1st
Strand cDNA Synthesis Kit. PCR product was detected using
SYBR Premix Ex Taq II Kit. Amplification cycle was applied
as 95◦C for 15 s, 55◦C for 5 s and 72◦C for 10 s. Primers
sequences were as follows: GAPDH (forward primer: F-5′-
AACGACCCCTTCATTGAC-3′ and reverse primer R-5′-
TCCACGACATACTCAGCAC-3′). MHC class I (H-2Kb)
(forward primer: F-5′- TACCAGCAGTACGCCTACGAC -3′
and reverse primer R-5′- GCGTTCCCGTTCTTCAGGTAT-3′).
qRT-PCRs were carried out by using a CFX96TM real-time
PCR system (Bio-Rad) using the relative quantification
methodology. The results were expressed as a ratio relative to
the GAPDH level. All reagents were purchased from Takara,
Japan.
Mouse Infection
Bacterial strains were dispersed in PBS and quantified with
Colony forming units (CFU) counting. Six week old female
C57BL/6 mice were infected with 2× 107 CFUs of either Msmeg-
V or Msmeg-PPE38 via intraperitoneal injection according to
previous report (Dheenadhayalan et al., 2006).
Bacteria Burden in Organs
Bacterial loads in lungs, liver, and spleen were evaluated at 1,
6, and 9 dpi, respectively. Briefly, the organs were aseptically
removed from euthanizedmice and homogenized in sterile saline
containing 0.05% Tween 80 (Sigma-Aldrich). Serial dilutions of
homogenized organs were plated on C7H10 agar plates. Plates
were incubated at 37◦C and colonies were counted after 3 days.
Immunohistochemical Detection of CD8+ T
Cells in Infected Organs
The histopathology was carried out as described earlier (Higgins
et al., 1999). In Brief, lungs, liver, and spleen of mice was
aseptically removed from euthanized animals and were fixed in
2.5% glutaraldehyde-paraformaldehyde mixture. Sections were
then stained with anti-CD8 (PE488) for visualization. DAPI
nuclear staining was used to identify cells. Microphotographs
were taken using an Olympus DP72 CCD camera (Olympus,
Japan) attached to the microscope. A group of three mice were
used at 6 dpi, and CD8+ T cells were counted manually from
three different fields of each mice (×400 time magnified).
Data Statistics
All data were generated from three independent experiments.
They were shown as Means ± SD and processed with Graphpad
software. Student t-test (two tailed) was performed to test the
significant differences between groups. p < 0.05 was considered
as significant.
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FIGURE 1 | PPE38 protein inhibited the MHC class I expression in macrophages. RAW264.7 cells were infected with either M. marinum strains (WT Mm,
Tn-MmPPE38, and Comp-MmPPE38, MOI = 1) or M. smegmatis strains (Msmeg-V, Msmeg-PPE38, and Msmeg-PPE68, MOI = 10). The expression of MHC class I
was detected by FACS at (A,B) 4 hpi for M. marinum strains or (C,D) 2 hpi for M. smegmatis strains by FACS analysis. (E) Total RNA was isolated from infected
RAW264.7 cells. The level of MHC class I was measured by qRT-PCR and expression levels were normalized to corresponding GAPDH levels. Data were generated
from four independent experiments. *p < 0.05.
RESULTS
Mycobacterium PPE38 Protein Reduced
MHC Class I Expression in RAW264.7
Based on our previous data, which showed that the MHC
class I pathway proteins TAP1 and TAP2 were significantly
downregulated by PPE38 (Wang et al., 2013), we hypothesized
that PPE38 might play a role in suppressing MHC class
I expression. To verify this, RAW264.7 cells were infected
with M. marinum (WT Mm), Mmppe38 mutant strain (Tn-
MmPPE38) or the complemented strain (Comp-MmPPE38),
respectively. As shown in Figures 1A,B, compared with the
WT Mm, more MHC class I proteins were observed on
the cell surface of macrophages after Tn-MmPPE38 infection,
indicating that macrophage expression of MHC class I on
the cell surface was inhibited by PPE38. Similar amounts
of MHC class I protein to that of the WT Mm were
observed when Comp-MmPPE38 was used. Furthermore, as
M. smegmatis lacks an endogenous homolog of the MTB
PPE38 protein, therefore, we expressed MTB PPE38 in M.
smegmatis (Msmeg-PPE38) (Figures 1A,B) and then used it
to infect macrophages. Similarly, the amount of MHC class
I was significantly reduced in RAW264.7 cells infected with
MS-PPE38, compared with the control strain harboring empty
vector (Msmeg-V) (Figures 1C,D). We also detected the effects
of another PPE protein, PPE68, on MHC class I expression,
but did not observe similar effects. In addition to studies of
cell surface expression of MHC class I, real-time quantitative
PCR was used to measure MHC class I H-2Kb mRNA
expression in macrophages after incubation with Msmeg-V or
Msmeg-PPE38. As showed in Figure 1E, significantly reduced
MHC class I transcript levels were observed when PPE38
was expressed, which was consistent with decreased MHC
class I protein levels described above. Taken together, the
results suggested that the PPE38 protein inhibited MHC class
I synthesis in macrophages, most likely at the transcriptional
level.
MTB PPE38 Protein Inhibits MHC Class I
Expression in Peritoneal Macrophages
Furthermore, the expression of MHC class I on mouse peritoneal
macrophages (PMs) were also examined. After infection with
Msmeg-V and Msmeg-PPE38, C57BL/6 mouse PMs were
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FIGURE 2 | PPE38 dampened the expression of MHC class I in peritoneal macrophages. C57BL/6 mice were infected with Msmeg-V and Msmeg-PPE38 (2
× 107), the peritoneal macrophages collected from infected mice were stained with FITC conjugated anti-CD11b mAbs, and PE-conjugated anti-MHC class I mAbs.
(A) Expression of MHC class I were analyzed by FACS from 1*106 cells at 6 hpi (gate R1–R3) and 1 dpi (gate R1′–R3′). Peritoneal macrophages were first gated as
CD11b+ (gate R3 and R3′), then two subgroup of PMs were observed as CD11bhighMHC class Ihigh (gate R1 and R1′) and CD11blowMHC class Ilow (gate R2 and
R2′). (B) Histograms and (C) bar graphs show the Mean Fluorescence Intensity of MHC class I of macrophages. (D,E) Isolated mouse peritoneal macrophages from
mice pretreated with 3% thioglycollate medium were cultured for 24 h and then infected with Msmeg-V and Msmeg-PPE38 (MOI = 10). The amount of MHC class I
was measured via FACS from 1*105 cells. Bar graphs show the mean ± SD, representing three independent experiments. *p < 0.05. **p < 0.01.
isolated and analyzed by fluorescence activated cell sorting
(FACS). As shown in Figure 2A, we firstly gated CD11b+ cells
comparing to the uninfected group. Then, the expression of
MHC class I was evaluated, and two distinct groups (CD11blow
MHC class Ilow and CD11bhigh MHC class Ihigh) PMs were
observed. At 6 hpi, the frequency of CD11blow MHC class
Ilow was significantly increased only in Msmeg-PPE38 group,
indicating that PPE38 could play a role in the generation of
CD11blow PMs. Consequently, when PMs were gated as a single
population based on CD11b and F4/80 expression (Figure 2),
as shown in Figures 2B,C, the MHC class I level in PMs of
the Msmg-PPE38 group was significantly lower than that in
the PMs of the Msmeg-V group at 6 h post infection (hpi)
and 1 day post infection (dpi). To assess the direct impact of
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FIGURE 3 | C57BL/6 mice infected with Msmeg-PPE38 showed reduced distribution of CD8+ T cells in infected organs as compared to mice infected
with Msmeg-V. The (A) spleen, (B) liver and (C) lungs sections of C57BL/6 mice either treated with PBS or infected with 2 × 107 of Msmeg-V or Msmeg-PPE38 at 6
dpi were stained with anti-CD8 antibody and DAPI. Histograms and bar graphs show the number of CD8+ T cells. Arrowheads show CD8+ T cell. Photographs of
representative sections were shown (× 400 time magnified). CD8+ T cells were counted manually from three different fields of each mice. Bar graphs show the mean
± SD, representing two independent experiments. *p < 0.05. **p < 0.01. ***p < 0.001, ****p < 0.0001.
PPE38 on MHC class I expression in PMs, isolated PMs from
mice pretreated with 3% thioglycollate medium were cultured
for 24 h, and then treated with Msmeg-V or Msmeg-PPE38.
PMs infected with Msmeg-V significantly upregulated MHC
class I, but PMs infected with Msmeg-PPE38 failed to do
so (Figures 2D,E). Consistent with what we have observed in
macrophage cell line (Figures 1D,E), we speculate that PPE38
could inhibit MHC class I expression in mycobacteria-infected
macrophages.
Decreased CD8+ T Cells were Elicited in
C57BL/6 Mice Infected with M. smegmatis
Expressing PPE38 Protein
CD8+ T cells will be recruited to infected organs post-MTB
infection (Tully et al., 2005). To further characterize the PPE38
protein function in MHC class I restricted CD8+ T cells
activation in vivo, the distribution of CD8+ T cells in different
mouse tissues was investigated. At 6 dpi, the number of CD8+
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FIGURE 4 | PPE38 inhibited CD8+ T response in infected spleen. Spleen cells derived from three C57BL/6 mice were collected at 6 dpi in each infected group.
(A) Representative flow cytometry profiles of CD8+ T cells which were gated first as CD3+/CD8+ cells (B) he expression of cell surface markers of CD8+ T cells
including CD44 and CD62L was examined by FACS analysis using the respective PE-Cy7 or PerCP-Cy5.5 mAbs. (C) Bar graphs show the mean ± SD percentages
of CD44highCD62Llow CD8+ T cells, representing two independent experiments. *p < 0.05.
T cells in the spleen (Figure 3A), liver (Figure 3B) and lungs
(Figure 3C) of mice infected by Msmeg-PPE38 was significantly
lower than that in the control strain. Strikingly, we found that
spleens isolated from Msmeg-V infected mice were much larger
than those obtained from the PBS and Msmeg-PPE38 groups
(data not shown). CD44 expression is an indicative marker for
effector/memory T-cells. To assess whether decreased MHC class
I expression mediated by PPE38 influenced specific stimulation
of CD8+ T cells from infected mice, we used FACS to analyze
the surface expression of CD62L and CD44 on CD8+ T cells.
Effector/memory T cells were reported previously to exhibit
a CD44highCD62Llow phenotype (Gerberick et al., 1997). The
generation of effector/memory T cells was increased, in line with
up-regulated CD44 expression in CD8+ T cells from Msmeg-
V-infected mice, compared with PBS control. This effect was
abrogated when PPE38 was expressed (Figure 4). Together, these
findings demonstrated that PPE38 inhibited macrophage MHC
class I expression and were associated with a decreased number
of effector/memory CD8+ T cells in vivo.
Survival of M. smegmatis in C57BL/6 Mice
is Enhanced When Expressing
Recombinant PPE38 Protein
We next assessed the effect of PPE38 on the survival of M.
smegmatis in C57BL/6 mice. Msmeg-V or Msmeg-PPE38 at
2 × 107 colony forming units (CFUs) were injected into the
mice intraperitoneally. The initial bacteria load was verified for
Msmeg-RvPPE38 and Msmeg-V in the spleen, liver, and lungs at
1 dpi (Figure 5A). Further CFU counts at 6 and 9 dpi indicated
that M. smegmatis expressing PPE38 persisted for a significantly
longer time period than Msmeg-V in all the organs, which is
correlated well with the above tissue immunohistochemical data.
The CFU of the MS-PPE38 strain was significantly higher than
that of the MS-V strain in all three organs at both 6 and 9 dpi.
In the lungs of Msmeg-V-infected mice, the mean CFU counts
were significantly lower at 6 dpi as compared with those of
infected with Msmeg-PPE38 strain and this trend also continued
to the later time point (9 dpi). Similar observations were made
in the liver and spleen, although the CFUs at 9 dpi were not as
significant as those at 6 dpi. Here, we also assessed the survival of
Msmeg-V andMsmeg-PPE38 in BALB/c mice (Figure 5B), while
no difference was observed. This observation might be due to
the limited function of manipulating MHC class I haplotypes by
PPE38 on a BALB/c background (Flynn et al., 1995). These data
suggested that PPE38 plays a vital role inmycobacterial virulence,
through dampening MHC class I response.
DISCUSSION
In the present study, we attempted to determine the role
played by PPE38 in inhibiting mycobacterial Ag presentation by
macrophages. Our data showed that the expression of MHC class
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FIGURE 5 | M. smegmatis survival is enhanced in the C57BL/6 mice by expressing PPE38. C57BL/6 mice and BALB/c mice were infected with MS-PPE38
and MS-V (2 × 107), and then the bacteria loads in lungs, liver and spleen were counted at 1, 6, and 9 dpi of C57BL/6 mice (A) and and BALB/c mice (B). Data
represent mean ± SD of five mice per group for each time point. *p < 0.05.
I in infected macrophages was inhibited by the Mycobacterium
PPE38 protein, which in turn influenced the numbers of CD8+ T
cells.
Although macrophages are known as antigen presenting cells
(APCs) that could present Ags to CD8+ T cells (Bermudez
et al., 1997, Teitelbaum et al., 1999; Overbergh et al., 2000),
the mechanisms whereby MTB is processed for presentation
by MHC class I molecules and how this process is regulated
remain unclear. In the current study, as measured by real-time
quantitative PCR and FACS, we found that the expression of
MHC class I on PMswas inhibited after exposure toM. smegmatis
expressing PPE38. We provide the evidence that PPE38 can
directly suppress MHC class I expression. In addition, PPE38-
expressing Msmeg intraperitoneal infection also rapidly induces
a population of CD11blowMHC classIlow subsets which largely
explains the significant decrease of MHC class I on PMs in
Msmeg-PPE38 group compared to Msmeg-V (Figures 2A,B).
Thus, Msmeg-PPE38 could affect MHC class I expression on
PMs through several ways in vivo. More studies are warranted
to dissect the underlying mechanisms for different situations.
The role of PPE38 protein in MTB pathogenesis might
be correlated with the genetic background of the host. In
general, C57BL/6 mice are relatively more resistant to MTB
infection than BALB/c mice (Flynn et al., 1995; Chackerian
and Behar, 2003; Arko-Mensah et al., 2009; Sergio et al.,
2015). In the current study, we have observed that the MTB
PPE38 protein only enhanced the survival of M. smegmatis in
C57BL/6 mice instead of BALB/c mice. One possible reason
for this discrepancy is due to the different MHC class I
haplotypes (Flynn et al., 1995). In addition, C57BL/6 mice
generate a stronger T helper (Th) 1 immune response, while
BALB/c mice favor a Th2-driven immune response (Kramnik
et al., 2000; Watanabe et al., 2004). While Th1 cytokines have
been implicated for host resistance against MTB (Munk and
Emoto, 1995; Hernandez-Pando et al., 1997; Power et al., 1998),
certain Th1 inflammatory cytokines could play a deleterious role
in anti-mycobacterial immunity under certain conditions. For
instance, our previous study indicated that PPE38 promoted
the secretion of host Th1 cytokines, especially TNF-alpha, and
led to severe pathogenesis in M. marinum-infected zebrafish,
including both tissue damage and bacterial dissemination (Dong
et al., 2012). In agreement with this, we found that the
expression of PPE38 in M. smegmatis could provide a benefit
for the survival of these bacteria in C57BL/6 mice, but not
BALB/c mice. More study is needed to further explore this
issue.
Tissue-resident macrophages are a heterogeneous
population(Sieweke and Allen, 2013). After infection with
Msmeg-V and Msmeg-PPE38, C57BL/6 mouse PMs were
analyzed by fluorescence activated cell sorting (FACS) marked
as CD11b+F4/80+. As reported before (Ghosn et al., 2010),
two PMs subsets defined as CD11bhighF4/80high and small
PMs CD11blowF4/80low coexist in infected C57BL/6 mice via
intraperitoneal injection (Figure 2). CD11bhighF4/80high PMs
was dominant in PBS group, but disappeared following infection
of M. smegmatis strains. Interestingly, CD11blowF4/80low PMs
were generated rapidly in Msmg-PPE38-infected mice as early
as 6 hpi. We speculate that similar CD11blowF4/80low PMs could
be generated in other organs, including lungs, spleen, and liver.
These macrophages express low levels of MHC class I molecules,
which may contribute to the lower proliferation of CD8+ T cells
and lower generation of effector/memory CD8+ T cells observed
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in this study. The recruitment of CD8+ T cells could also be
affected by these PMs. These ideas can be tested and confirmed
in our future studies.
The expression of virulence genes by MTB is largely in a time-
dependent manner post infection, which reflects the adaption
of bacilli to the changes of the surrounding environment
(Ramakrishnan et al., 2000; Mehrotra et al., 2014; Calder et al.,
2015). PPE38 was highly expressed after 90 dpi in guinea pigs,
but not at the early stage (30 dpi) (Kruh et al., 2010). This
might be correlated with the recruitment of CD8+ T cells, which
only increased significantly after day 40 (Grover et al., 2009). In
support of this, our results demonstrated that the proliferation of
M.marinum in macrophages is independent of PPE38 expression
(Figure 3A). In addition, there was no significant difference in
proliferation of M. marinum WT Mm and the PPE38 mutant
strains at 2, 4, and 7 dpi in zebrafish larvae, indicating that PPE38
might have only a trivial function in evading host innate immune
responses (Figures S3B,C). By contrast, during the infection
of adult zebrafish, which have adaptive immunity, the PPE38
mutant was attenuated significantly compared with the WT Mm
(Dong et al., 2012), indicating the indispensable role of PPE38 in
interfering with host adaptive immune responses.
Until now, the mechanisms of the protective immune
response against TB have not been fully understood. Only few
MTB proteins were proved to play a role in inhibiting alternate
Ag processing. 19kD lipoprotein, plays role in inhibiting alternate
MHC class I Ag processing of macrophages, while without
disturbingMHC class I expression (Tobian et al., 2003). Recently,
PE_PGRS47 was identified as an factor which could inhibit
class II-restricted Ag presentation by dendritic cells (Saini et al.,
2016). Our study showed that fewer MHC class I was expressed
when MTB PPE38 was expressed in M. smegmatis. Also, PPE38
participates in manipulating CD8+ T cells response, which in
turn benefitsM. smegmatis survival in host. These findings from
this study helped us to better understand the unique function of
PPE38 protein on host immunity, and provide an ideal target for
future tuberculosis vaccine design.
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